title: Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes.
authors.affiliation: The Carl and Edyth Lindner Center for Clinical Cardiovascular Research, Cincinnati, OH 45219, USA. lindner@fuse.net
authors.forename: D J
authors.initials: DJ
authors.lastname: Kereiakes
authors.forename: M
authors.initials: M
authors.lastname: McDonald
authors.forename: T
authors.initials: T
authors.lastname: Broderick
authors.forename: E M
authors.initials: EM
authors.lastname: Roth
authors.forename: D D
authors.initials: DD
authors.lastname: Whang
authors.forename: L H
authors.initials: LH
authors.lastname: Martin
authors.forename: W L
authors.initials: WL
authors.lastname: Howard
authors.forename: J
authors.initials: J
authors.lastname: Schneider
authors.forename: T
authors.initials: T
authors.lastname: Shimshak
authors.forename: C W
authors.initials: CW
authors.lastname: Abbottsmith
mesh_terms: D000077284:Abciximab; D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004562:Electrocardiography / Q000187:drug effects; D000077542:Eptifibatide; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D000077466:Tirofiban; D000077542:Eptifibatide; D000077284:Abciximab